Day Range6.100 - 6.250 | 52 Wk Range0 - 13.660 | Open / Close6.250 / 6.100 | Float / Outstanding36.560M / 42.134M |
Vol / Avg.2.289K / 7.858K | Mkt Cap260.178M | P/E- | 50d Avg. Price4.940 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float36.560M | EPS-1.390 |
Inventiva Stock (NASDAQ: IVA) stock price, news, charts, stock research, profile.
Day Range6.100 - 6.250 | 52 Wk Range0 - 13.660 | Open / Close6.250 / 6.100 | Float / Outstanding36.560M / 42.134M |
Vol / Avg.2.289K / 7.858K | Mkt Cap260.178M | P/E- | 50d Avg. Price4.940 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float36.560M | EPS-1.390 |
FY 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-06 | ||||||
REV |
H1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.790 | ||||||
REV | 73.308K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Inventiva (NASDAQ: IVA) through any online brokerage.
Other companies in Inventiva’s space includes: Molecular Partners (NASDAQ:MOLN), Innate Pharma (NASDAQ:IPHA), KalVista Pharma (NASDAQ:KALV), Larimar Therapeutics (NASDAQ:LRMR) and LianBio (NASDAQ:LIAN).
The latest price target for Inventiva (NASDAQ: IVA) was reported by HC Wainwright & Co. on Friday, September 23, 2022. The analyst firm set a price target for 36.00 expecting IVA to rise to within 12 months (a possible 483.00% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Inventiva (NASDAQ: IVA) is $6.175 last updated February 3, 2023 at 8:00 PM UTC.
There are no upcoming dividends for Inventiva.
Inventiva’s FY earnings are confirmed for Monday, March 6, 2023.
There is no upcoming split for Inventiva.
Inventiva is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Inventiva Stock (NASDAQ: IVA) stock price, news, charts, stock research, profile.
Day Range6.100 - 6.250 | 52 Wk Range0 - 13.660 | Open / Close6.250 / 6.100 | Float / Outstanding36.560M / 42.134M |
Vol / Avg.2.289K / 7.858K | Mkt Cap260.178M | P/E- | 50d Avg. Price4.940 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float36.560M | EPS-1.390 |
FY 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-06 | ||||||
REV |
H1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.790 | ||||||
REV | 73.308K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Inventiva (NASDAQ: IVA) through any online brokerage.
Other companies in Inventiva’s space includes: Molecular Partners (NASDAQ:MOLN), Innate Pharma (NASDAQ:IPHA), KalVista Pharma (NASDAQ:KALV), Larimar Therapeutics (NASDAQ:LRMR) and LianBio (NASDAQ:LIAN).
The latest price target for Inventiva (NASDAQ: IVA) was reported by HC Wainwright & Co. on Friday, September 23, 2022. The analyst firm set a price target for 36.00 expecting IVA to rise to within 12 months (a possible 483.00% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Inventiva (NASDAQ: IVA) is $6.175 last updated February 3, 2023 at 8:00 PM UTC.
There are no upcoming dividends for Inventiva.
Inventiva’s FY earnings are confirmed for Monday, March 6, 2023.
There is no upcoming split for Inventiva.
Inventiva is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Inventiva Stock (NASDAQ: IVA) stock price, news, charts, stock research, profile.
Day Range6.100 - 6.250 | 52 Wk Range0 - 13.660 | Open / Close6.250 / 6.100 | Float / Outstanding36.560M / 42.134M |
Vol / Avg.2.289K / 7.858K | Mkt Cap260.178M | P/E- | 50d Avg. Price4.940 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float36.560M | EPS-1.390 |
FY 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-06 | ||||||
REV |
H1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.790 | ||||||
REV | 73.308K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Inventiva (NASDAQ: IVA) through any online brokerage.
Other companies in Inventiva’s space includes: Molecular Partners (NASDAQ:MOLN), Innate Pharma (NASDAQ:IPHA), KalVista Pharma (NASDAQ:KALV), Larimar Therapeutics (NASDAQ:LRMR) and LianBio (NASDAQ:LIAN).
The latest price target for Inventiva (NASDAQ: IVA) was reported by HC Wainwright & Co. on Friday, September 23, 2022. The analyst firm set a price target for 36.00 expecting IVA to rise to within 12 months (a possible 483.00% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Inventiva (NASDAQ: IVA) is $6.175 last updated February 3, 2023 at 8:00 PM UTC.
There are no upcoming dividends for Inventiva.
Inventiva’s FY earnings are confirmed for Monday, March 6, 2023.
There is no upcoming split for Inventiva.
Inventiva is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Inventiva Stock (NASDAQ: IVA) stock price, news, charts, stock research, profile.
Day Range6.100 - 6.250 | 52 Wk Range0 - 13.660 | Open / Close6.250 / 6.100 | Float / Outstanding36.560M / 42.134M |
Vol / Avg.2.289K / 7.858K | Mkt Cap260.178M | P/E- | 50d Avg. Price4.940 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float36.560M | EPS-1.390 |
FY 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-06 | ||||||
REV |
H1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.790 | ||||||
REV | 73.308K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Inventiva (NASDAQ: IVA) through any online brokerage.
Other companies in Inventiva’s space includes: Molecular Partners (NASDAQ:MOLN), Innate Pharma (NASDAQ:IPHA), KalVista Pharma (NASDAQ:KALV), Larimar Therapeutics (NASDAQ:LRMR) and LianBio (NASDAQ:LIAN).
The latest price target for Inventiva (NASDAQ: IVA) was reported by HC Wainwright & Co. on Friday, September 23, 2022. The analyst firm set a price target for 36.00 expecting IVA to rise to within 12 months (a possible 483.00% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Inventiva (NASDAQ: IVA) is $6.175 last updated February 3, 2023 at 8:00 PM UTC.
There are no upcoming dividends for Inventiva.
Inventiva’s FY earnings are confirmed for Monday, March 6, 2023.
There is no upcoming split for Inventiva.
Inventiva is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Inventiva Stock (NASDAQ: IVA) stock price, news, charts, stock research, profile.
Day Range6.100 - 6.250 | 52 Wk Range0 - 13.660 | Open / Close6.250 / 6.100 | Float / Outstanding36.560M / 42.134M |
Vol / Avg.2.289K / 7.858K | Mkt Cap260.178M | P/E- | 50d Avg. Price4.940 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float36.560M | EPS-1.390 |
FY 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-06 | ||||||
REV |
H1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.790 | ||||||
REV | 73.308K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Inventiva (NASDAQ: IVA) through any online brokerage.
Other companies in Inventiva’s space includes: Molecular Partners (NASDAQ:MOLN), Innate Pharma (NASDAQ:IPHA), KalVista Pharma (NASDAQ:KALV), Larimar Therapeutics (NASDAQ:LRMR) and LianBio (NASDAQ:LIAN).
The latest price target for Inventiva (NASDAQ: IVA) was reported by HC Wainwright & Co. on Friday, September 23, 2022. The analyst firm set a price target for 36.00 expecting IVA to rise to within 12 months (a possible 483.00% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Inventiva (NASDAQ: IVA) is $6.175 last updated February 3, 2023 at 8:00 PM UTC.
There are no upcoming dividends for Inventiva.
Inventiva’s FY earnings are confirmed for Monday, March 6, 2023.
There is no upcoming split for Inventiva.
Inventiva is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Inventiva Stock (NASDAQ: IVA) stock price, news, charts, stock research, profile.
Day Range6.100 - 6.250 | 52 Wk Range0 - 13.660 | Open / Close6.250 / 6.100 | Float / Outstanding36.560M / 42.134M |
Vol / Avg.2.289K / 7.858K | Mkt Cap260.178M | P/E- | 50d Avg. Price4.940 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float36.560M | EPS-1.390 |
FY 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-06 | ||||||
REV |
H1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.790 | ||||||
REV | 73.308K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Inventiva (NASDAQ: IVA) through any online brokerage.
Other companies in Inventiva’s space includes: Molecular Partners (NASDAQ:MOLN), Innate Pharma (NASDAQ:IPHA), KalVista Pharma (NASDAQ:KALV), Larimar Therapeutics (NASDAQ:LRMR) and LianBio (NASDAQ:LIAN).
The latest price target for Inventiva (NASDAQ: IVA) was reported by HC Wainwright & Co. on Friday, September 23, 2022. The analyst firm set a price target for 36.00 expecting IVA to rise to within 12 months (a possible 483.00% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Inventiva (NASDAQ: IVA) is $6.175 last updated February 3, 2023 at 8:00 PM UTC.
There are no upcoming dividends for Inventiva.
Inventiva’s FY earnings are confirmed for Monday, March 6, 2023.
There is no upcoming split for Inventiva.
Inventiva is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Inventiva Stock (NASDAQ: IVA) stock price, news, charts, stock research, profile.
Day Range6.100 - 6.250 | 52 Wk Range0 - 13.660 | Open / Close6.250 / 6.100 | Float / Outstanding36.560M / 42.134M |
Vol / Avg.2.289K / 7.858K | Mkt Cap260.178M | P/E- | 50d Avg. Price4.940 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float36.560M | EPS-1.390 |
FY 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-06 | ||||||
REV |
H1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.790 | ||||||
REV | 73.308K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Inventiva (NASDAQ: IVA) through any online brokerage.
Other companies in Inventiva’s space includes: Molecular Partners (NASDAQ:MOLN), Innate Pharma (NASDAQ:IPHA), KalVista Pharma (NASDAQ:KALV), Larimar Therapeutics (NASDAQ:LRMR) and LianBio (NASDAQ:LIAN).
The latest price target for Inventiva (NASDAQ: IVA) was reported by HC Wainwright & Co. on Friday, September 23, 2022. The analyst firm set a price target for 36.00 expecting IVA to rise to within 12 months (a possible 483.00% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Inventiva (NASDAQ: IVA) is $6.175 last updated February 3, 2023 at 8:00 PM UTC.
There are no upcoming dividends for Inventiva.
Inventiva’s FY earnings are confirmed for Monday, March 6, 2023.
There is no upcoming split for Inventiva.
Inventiva is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Inventiva Stock (NASDAQ: IVA) stock price, news, charts, stock research, profile.
Day Range6.100 - 6.250 | 52 Wk Range0 - 13.660 | Open / Close6.250 / 6.100 | Float / Outstanding36.560M / 42.134M |
Vol / Avg.2.289K / 7.858K | Mkt Cap260.178M | P/E- | 50d Avg. Price4.940 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float36.560M | EPS-1.390 |
FY 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-06 | ||||||
REV |
H1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.790 | ||||||
REV | 73.308K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Inventiva (NASDAQ: IVA) through any online brokerage.
Other companies in Inventiva’s space includes: Molecular Partners (NASDAQ:MOLN), Innate Pharma (NASDAQ:IPHA), KalVista Pharma (NASDAQ:KALV), Larimar Therapeutics (NASDAQ:LRMR) and LianBio (NASDAQ:LIAN).
The latest price target for Inventiva (NASDAQ: IVA) was reported by HC Wainwright & Co. on Friday, September 23, 2022. The analyst firm set a price target for 36.00 expecting IVA to rise to within 12 months (a possible 483.00% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Inventiva (NASDAQ: IVA) is $6.175 last updated February 3, 2023 at 8:00 PM UTC.
There are no upcoming dividends for Inventiva.
Inventiva’s FY earnings are confirmed for Monday, March 6, 2023.
There is no upcoming split for Inventiva.
Inventiva is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.